CD69 Targeting Enhances Anti-vaccinia Virus Immunity.
Animals
Antibodies, Monoclonal
/ administration & dosage
Antigens, CD
/ administration & dosage
Antigens, Differentiation, T-Lymphocyte
/ administration & dosage
Disease Models, Animal
Humans
Immunologic Factors
/ administration & dosage
Killer Cells, Natural
/ immunology
Lectins, C-Type
/ administration & dosage
Mice
Mice, Transgenic
Signal Transduction
T-Lymphocytes
/ immunology
TOR Serine-Threonine Kinases
/ metabolism
Vaccinia
/ immunology
Vaccinia virus
/ immunology
MAb
immunotherapy
infection clearance
innate immunity
vaccinia virus
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
01 10 2019
01 10 2019
Historique:
received:
15
04
2019
accepted:
07
07
2019
pubmed:
19
7
2019
medline:
3
6
2020
entrez:
19
7
2019
Statut:
epublish
Résumé
CD69 is highly expressed on the leukocyte surface upon viral infection, and its regulatory role in the vaccinia virus (VACV) immune response has been recently demonstrated using CD69
Identifiants
pubmed: 31315995
pii: JVI.00553-19
doi: 10.1128/JVI.00553-19
pmc: PMC6744249
pii:
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antigens, CD
0
Antigens, Differentiation, T-Lymphocyte
0
CD69 antigen
0
Immunologic Factors
0
Lectins, C-Type
0
mTOR protein, mouse
EC 2.7.1.1
TOR Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
J Exp Med. 2003 May 5;197(9):1093-106
pubmed: 12732655
J Clin Invest. 2003 Sep;112(6):872-82
pubmed: 12975472
Nature. 2004 Jan 22;427(6972):355-60
pubmed: 14737169
J Immunol. 2004 May 15;172(10):6265-71
pubmed: 15128815
Blood. 2005 Jun 1;105(11):4399-406
pubmed: 15692061
Trends Immunol. 2005 Mar;26(3):136-40
pubmed: 15745855
J Leukoc Biol. 2006 Dec;80(6):1233-41
pubmed: 16921025
PLoS One. 2007 Aug 15;2(8):e707
pubmed: 17710125
J Immunol. 2007 Oct 1;179(7):4766-74
pubmed: 17878375
J Immunol. 2008 Feb 1;180(3):1592-7
pubmed: 18209055
Cardiovasc Res. 2009 Jan 1;81(1):197-205
pubmed: 18703531
J Gen Virol. 2008 Nov;89(Pt 11):2877-81
pubmed: 18931086
Cell Signal. 2009 Feb;21(2):293-300
pubmed: 19000755
J Immunol. 2009 Jan 1;182(1):111-20
pubmed: 19109141
J Clin Invest. 2009 Mar;119(3):492-503
pubmed: 19197139
J Exp Med. 2009 Sep 28;206(10):2141-9
pubmed: 19752185
Immunol Cell Biol. 2010 Oct;88(7):707-15
pubmed: 20440294
Blood. 2011 Jan 13;117(2):419-28
pubmed: 20585044
J Allergy Clin Immunol. 2010 Aug;126(2):355-65, 365.e1-3
pubmed: 20621339
Nat Immunol. 2010 Nov;11(11):1047-56
pubmed: 20852647
Circulation. 2010 Oct 5;122(14):1396-404
pubmed: 20855659
Clin Infect Dis. 2011 Jan 1;52(1):1-7
pubmed: 21148512
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35
pubmed: 21157483
PLoS One. 2011 Feb 15;6(2):e14626
pubmed: 21347224
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
Vaccine. 2011 Oct 26;29(46):8309-16
pubmed: 21907749
Annu Rev Immunol. 2012;30:39-68
pubmed: 22136167
Blood. 2012 Mar 15;119(11):2478-88
pubmed: 22279055
J Leukoc Biol. 2012 Jul;92(1):145-58
pubmed: 22544938
PLoS One. 2012;7(10):e48593
pubmed: 23119065
Nat Med. 2013 Sep;19(9):1166-72
pubmed: 23933982
J Gen Virol. 2013 Nov;94(Pt 11):2367-92
pubmed: 23999164
Nat Immunol. 2013 Dec;14(12):1294-301
pubmed: 24162776
Mol Cell Biol. 2014 Jul;34(13):2479-87
pubmed: 24752896
J Autoimmun. 2014 Dec;55:51-62
pubmed: 24934597
FASEB J. 2015 Dec;29(12):5006-17
pubmed: 26296369
J Virol. 2016 Jun 24;90(14):6464-6474
pubmed: 27147744
J Exp Med. 2016 May 30;213(6):951-66
pubmed: 27217536
Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):null
pubmed: 28108486
Eur J Immunol. 2017 Jun;47(6):946-953
pubmed: 28475283
Sci Immunol. 2016 Sep 16;1(3):eaaf9154
pubmed: 28783682
Leukemia. 2018 Jun;32(6):1445-1457
pubmed: 29483712
Mol Cell Biol. 1986 Sep;6(9):3191-9
pubmed: 3537732
Cancer Immunol Immunother. 1986;23(2):125-9
pubmed: 3779714
Tissue Antigens. 1996 Jul;48(1):65-8
pubmed: 8864178